Substituted 7-deazapurine ribonucleosides for therapeutic uses

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F17%3A73586842" target="_blank" >RIV/61989592:15110/17:73586842 - isvavai.cz</a>

Result on the web

<a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/9586986" target="_blank" >http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/9586986</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Substituted 7-deazapurine ribonucleosides for therapeutic uses

Original language description

The invention provides compounds of formula I, wherein R and R´ have values defined in the specification and a pharmaceutically acceptable salt thereof, or an optical isomer thereof, or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.

Czech name

—

Czech description

—

Type

P - Patent

CEP classification

—

OECD FORD branch

30204 - Oncology

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2017

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID

US 9,586,986

Publisher

US001 -

Publisher name

United States Patent and Trademark Office (USPTO)

Place of publication

Alexandria

Publication country

US - UNITED STATES

Date of acceptance

Mar 7, 2017

Owner name

ÚOCHB AV ČR, v.v.i.; Univerzita Palackého v Olomouci

Method of use

A - Výsledek využívá pouze poskytovatel

Usage type

A - K využití výsledku jiným subjektem je vždy nutné nabytí licence